NOSTRIN

Across TCGA pan-cancer cohorts, NOSTRIN Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated NOSTRIN data layer compared with 23 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher NOSTRIN Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated NOSTRIN expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

HNSC, BLCA, and SKCM are the cancer types where NOSTRIN Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.390	0.771	<.001	9	view →
BLCA	DFS	Median	III,IV	0.195	0.576	.007	9	view →
SKCM	DFS	Median	II,III,IV	1.000	0.557	.011	8	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

NOSTRIN–HNSC (OS)

Open the HNSC breakdown →